Former Barrow and Furness MP Simon Fell chaired a taskforce which developed a vision for Ulverston Life Science and Advanced Manufacturing Park on the former GSK site, which had been tipped to create ...

Multinational pharmaceutical company GSK’s commitment to invest up to $800 million in its facility near Marietta may have ...

The state-of-the-art biologics facility, acquired by Syngene USA Inc., a wholly owned subsidiary of Syngene, from Emergent ...

One of the most highly anticipated FDA decisions this month is for Alnylam Pharmaceuticals, which is seeking to expand the ...

Expected to enhance global innovator flexibility with biologics drug substance facility in Baltimore BANGALORE, India, March ...

Pharmaceutical majors AstraZeneca and GSK have partnered with competitor Takeda and nine suppliers to accelerate the adoption ...

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, ...

The US FDA has ordered BioNTech to immediately halt its Phase I/II trial of BNT165e, a malaria vaccine candidate, pending ...

Godrej Agrovet's board approved the acquisition of the remaining 48.06 percent stake in Creamline Dairy Products, which is ...

Transthyretin Amyloid Cardiomyopathy Treatment Market is estimated to be valued at US$ 1.69 Bn in 2023, and is expected to exhibit a CAGR of 31.1% by 2030. Mr. Shah Coherent Market Insights Pvt. Ltd.